AU2018288071A1 - Abuse deterrent oral solid dosage form - Google Patents

Abuse deterrent oral solid dosage form Download PDF

Info

Publication number
AU2018288071A1
AU2018288071A1 AU2018288071A AU2018288071A AU2018288071A1 AU 2018288071 A1 AU2018288071 A1 AU 2018288071A1 AU 2018288071 A AU2018288071 A AU 2018288071A AU 2018288071 A AU2018288071 A AU 2018288071A AU 2018288071 A1 AU2018288071 A1 AU 2018288071A1
Authority
AU
Australia
Prior art keywords
alkalizer
dosage form
abuse
millimoles
release form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018288071A
Other languages
English (en)
Inventor
Nitin Dharmadhikari
Bramhanand HANAMANNAVAR
Abhishek Jain
Umesh Pai
Yashoraj Zala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharma Advanced Research Co Ltd
Original Assignee
Sun Pharma Advanced Research Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Research Co Ltd filed Critical Sun Pharma Advanced Research Co Ltd
Publication of AU2018288071A1 publication Critical patent/AU2018288071A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2018288071A 2017-06-23 2018-06-22 Abuse deterrent oral solid dosage form Abandoned AU2018288071A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201621044051 2017-06-23
IN201621044051 2017-06-23
PCT/IN2018/050410 WO2018235104A2 (en) 2017-06-23 2018-06-22 Abuse deterrent oral solid dosage form

Publications (1)

Publication Number Publication Date
AU2018288071A1 true AU2018288071A1 (en) 2020-02-06

Family

ID=64736917

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018288071A Abandoned AU2018288071A1 (en) 2017-06-23 2018-06-22 Abuse deterrent oral solid dosage form

Country Status (7)

Country Link
US (1) US11439600B2 (enExample)
EP (1) EP3641734A4 (enExample)
JP (1) JP7125436B2 (enExample)
CN (1) CN110869007B (enExample)
AU (1) AU2018288071A1 (enExample)
CA (1) CA3067945A1 (enExample)
WO (1) WO2018235104A2 (enExample)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765178B2 (en) * 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
RU2011123377A (ru) * 2008-11-14 2012-12-20 Портола Фармасьютиклз, Инк. ТВЕРДАЯ КОМПОЗИЦИЯ ДЛЯ КОНТРОЛИРУЕМОГО ВЫСВОБОЖДЕНИЯ АКТИВНЫХ ИОНИЗИРУЕМЫХ АГЕНТОВ, ХАРАКТЕРИЗУЮЩИХСЯ НИЗКОЙ РАСТВОРИМОСТЬЮ В ВОДЕ ПРИ НИЗКИХ ЗНАЧЕНИЯХ pН, И СПОСОБЫ ЕЕ ПРИМЕНЕНИЯ
JP2014505736A (ja) * 2011-02-17 2014-03-06 キューアールエックスファーマ リミテッド 固体投薬形態の乱用を防止するための技術
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
WO2014145195A1 (en) * 2013-03-15 2014-09-18 Cerovene, Inc. Pharmaceuticals comprising a ph-dependent component and ph-raising agent
WO2015065547A1 (en) * 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
JP6510628B2 (ja) * 2014-03-26 2019-05-15 サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド 乱用防止即時放出性被覆リザーバ固体剤形
CA2910865C (en) * 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
CA2970065A1 (en) * 2014-12-08 2016-06-16 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
WO2016120892A1 (en) 2015-01-29 2016-08-04 Sun Pharma Advanced Research Company Ltd. Abuse deterrent controlled release solid dosage form
WO2017009865A1 (en) 2015-07-10 2017-01-19 Sun Pharma Advanced Research Company Ltd. Multiple pill abuse-resistant immediate release solid dosage form of hydrocodone
US20170157052A1 (en) * 2015-12-08 2017-06-08 Cima Labs Inc. Immediate release dosage forms that deter abuse by oral ingestion of multiple dosage units

Also Published As

Publication number Publication date
US11439600B2 (en) 2022-09-13
CA3067945A1 (en) 2018-12-27
JP7125436B2 (ja) 2022-08-24
WO2018235104A2 (en) 2018-12-27
EP3641734A4 (en) 2021-03-17
US20200222329A1 (en) 2020-07-16
WO2018235104A3 (en) 2019-07-18
EP3641734A2 (en) 2020-04-29
CN110869007A (zh) 2020-03-06
JP2020524697A (ja) 2020-08-20
CN110869007B (zh) 2022-10-14

Similar Documents

Publication Publication Date Title
AU2008286914B2 (en) Abuse resistant drugs, method of use and method of making
US20100092557A1 (en) Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic
AU2018232854B2 (en) Novel dosage form
WO2009015734A2 (en) Dosage form comprising immediate release naproxen and sustained release opioid analgesic
US11439600B2 (en) Abuse deterrent oral solid dosage form
WO2017192608A1 (en) Immediate release drug formulation combining opioid and nonopioid analgesics with abuse deterrence and overdose protection

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application